Addex Therapeutics Ltd - stock earnings
ADXN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.9 million USD | 357961 USD |
| 2023Q2 | -3.0 million USD | 701756 USD |
| 2023Q1 | -2.6 million USD | 548014 USD |
| 2022Q4 | -3.9 million USD | 640762 USD |
| 2022Q3 | -4.2 million USD | 419824 USD |
| 2022Q2 | -7.6 million USD | 192134 USD |
| 2022Q1 | -6.3 million USD | 256465 USD |
| 2021Q4 | -4.9 million USD | 435887 USD |
| 2021Q3 | -3.9 million USD | 731917 USD |
| 2021Q2 | -5.1 million USD | 1.1 million USD |
| 2021Q1 | -2.8 million USD | 894281 USD |
| 2020Q4 | -2.4 million USD | 2.0 million USD |
| 2020Q3 | -3.6 million USD | 29613 USD |
| 2020Q2 | -3.3 million USD | 908868 USD |
| 2020Q1 | -3.8 million USD | 1.1 million USD |
| 2019Q4 | -3.8 million USD | 1.1 million USD |
| 2019Q3 | -3.6 million USD | 506805 USD |
| 2019Q2 | -4.6 million USD | 531920 USD |
| 2019Q1 | -3.1 million USD | 704506 USD |
| 2018Q4 | -2.0 million USD | 678765 USD |
| 2018Q3 | -2.0 million USD | 683409 USD |
| 2018Q2 | 1.2 million USD | 2.7 million USD |
| 2018Q1 | 1.2 million USD | 2.8 million USD |
| 2017Q4 | -762972 USD | 139556 USD |
| 2017Q3 | -769273 USD | 140709 USD |
| 2017Q2 | -935443 USD | 118693 USD |
| 2017Q1 | -893251 USD | 113339 USD |
| 2016Q4 | -817676 USD | 63004 USD |
| 2016Q3 | -861487 USD | 66380 USD |
| 2016Q2 | -758475 USD | 144803 USD |
| 2016Q1 | -769476 USD | 146904 USD |
| 2015Q4 | -693721 USD | 355167 USD |
| 2015Q3 | -706111 USD | 361510 USD |
| 2015Q2 | -1.5 million USD | 48356 USD |
| 2015Q1 | -1.5 million USD | 46263 USD |
| 2014Q4 | -406959 USD | 155684 USD |
| 2014Q3 | -423077 USD | 161850 USD |
| 2014Q2 | -544496 USD | ? USD |
| 2014Q1 | -547051 USD | ? USD |
| 2013Q4 | -295818 USD | 1.5 million USD |
| 2013Q3 | -289899 USD | 1.5 million USD |
| 2013Q2 | -7.4 million USD | 75198 USD |
| 2013Q1 | -7.3 million USD | 74846 USD |
| 2012Q4 | -6.4 million USD | ? USD |
| 2012Q3 | -6.3 million USD | ? USD |
ADXN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.5 million USD | 2.4 million USD |
| 2022 | -22.5 million USD | 1.5 million USD |
| 2021 | -16.8 million USD | 3.2 million USD |
| 2020 | -14.3 million USD | 4.0 million USD |
| 2019 | -15.3 million USD | 2.9 million USD |
| 2018 | -1.7 million USD | 6.1 million USD |
| 2017 | -3.4 million USD | 510840 USD |
| 2016 | -3.1 million USD | 17025 USD |
| 2015 | -4.3 million USD | 40789 USD |
| 2014 | -1.8 million USD | 86398 USD |
| 2013 | -16.3 million USD | 103428 USD |
| 2012 | -29.1 million USD | ? USD |
| 2011 | -33.1 million USD | 3.0 million USD |
| 2010 | -36.0 million USD | 2.1 million USD |
| 2009 | -41.3 million USD | 4.0 million USD |
| 2008 | -20.7 million USD | 25.1 million USD |
| 2007 | -31.0 million USD | 429924 USD |
| 2006 | -16.9 million USD | 3.9 million USD |
ADXN
Price: $16.10
52 week price:
Earnings Per Share: -20.01 USD
P/E Ratio: -0.51
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 497200
Market Capitalization: 19.8 million